18.62
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché TNXP Giù?
Forum
Previsione
Frazionamento azionario
Tonix Pharmaceuticals Holding Corp Borsa (TNXP) Ultime notizie
Sentiment analysis tools applied to Tonix Pharmaceuticals Holding Corp.July 2025 Sector Moves & Safe Entry Point Alerts - newser.com
Tonix Pharmaceuticals (TNXP) Showcases Promising Vaccine Data at - GuruFocus
Tonix advances mpox vaccine candidate TNX-801 with promising data - Investing.com
Tonix advances mpox vaccine candidate TNX-801 with promising data By Investing.com - Investing.com UK
14‑Month durability: Tonix TNX-801 single‑dose mpox vaccine protects across multiple preclinical models - Stock Titan
Tonix Pharmaceuticals Holding Corp. stock retracement – recovery analysisEarnings Growth Report & Pattern Based Trade Signal System - newser.com
How to recover losses in Tonix Pharmaceuticals Holding Corp. stockWeekly Volume Report & Short-Term High Return Strategies - newser.com
Using portfolio simulators with Tonix Pharmaceuticals Holding Corp. includedQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - newser.com
Automated trading signals detected on Tonix Pharmaceuticals Holding Corp.2025 EndofYear Setup & Risk Managed Investment Signals - newser.com
Tonix CEO presents anti-CD154 antibody research at Japan transplant congress - Investing.com Nigeria
Tonix Pharmaceuticals (TNXP) Highlights Advancements in Transpla - GuruFocus
How Tonix Pharmaceuticals Holding Corp. stock performs after earningsJuly 2025 Movers & High Yield Equity Trading Tips - newser.com
Tonix Pharmaceuticals Presented an Update on Fc-modified - GlobeNewswire
Phase 1 safety & biomarker data lead Tonix's TNX-1500 toward Phase 2 for kidney transplant prevention - Stock Titan
Can Tonix Pharmaceuticals Holding Corp. recover in the next quarterJuly 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
Backtesting results for Tonix Pharmaceuticals Holding Corp. trading strategiesWeekly Market Outlook & Daily Profit Focused Screening - newser.com
Analyzing Tonix Pharmaceuticals Holding Corp. with risk reward ratio chartsJuly 2025 Breakouts & Smart Money Movement Tracker - newser.com
Tonix Pharmaceuticals Holding Corp. stock daily chart insightsJuly 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Tonix Pharmaceuticals (NASDAQ:TNXP) - MarketBeat
Fibromyalgia Market Expected to Gain Momentum Through 2034, According to DelveInsight | UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, Tonix Pharma, UCB Biopharma SRL, GSK - Barchart.com
Fibromyalgia Market Expected to Gain Momentum Through 2034, - openPR.com
Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025 - The Manila Times
Tonix Pharmaceuticals to Present at World Vaccine Congress–Europe 2025, Featuring Discussions on TNX-801 Mpox Vaccine - Quiver Quantitative
Detecting price anomalies in Tonix Pharmaceuticals Holding Corp. with AI2025 Sector Review & Real-Time Buy Signal Notifications - newser.com
What analysts say about Tonix Pharmaceuticals Holding Corp stockResistance Breakout Alerts & Affordable Growth Strategies - earlytimes.in
Tonix Pharmaceuticals (TNXP) Plans New Phase 2 Trials for Key Tr - GuruFocus
Tonix Pharma Plans Phase 2 Trial for 2026 - TipRanks
Tonix to advance cyclobenzaprine into phase 2 for depression - Seeking Alpha
Is Tonix Pharmaceuticals Holding Corp. trending in predictive chart models2025 Investor Takeaways & Daily Price Action Insights - newser.com
Custom watchlist performance reports with Tonix Pharmaceuticals Holding Corp.2025 Valuation Update & Safe Capital Growth Tips - newser.com
What data driven models say about Tonix Pharmaceuticals Holding Corp.’s futureWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Tonix Pharmaceuticals (NASDAQ:TNXP) Downgraded by Wall Street Zen to "Sell" - MarketBeat
Tonix Pharmaceuticals advances TNX-2900 into Phase 2 trial for Prader-Willi Syndrome - Proactive financial news
Tonix Pharma Appoints New Head of Market Access - MSN
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access - Sahm
Tonix Pharmaceuticals appoints Ganesh Kamath as head of market access By Investing.com - Investing.com Nigeria
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):